ans69 = ['- FACT-G (Version 4)\n- EQ-5D-5L Questionnaire', 'None found.', 'None found.', '- EQ-5D-5L, EuroQol group\n- FACT-G, Functional Assessment of Cancer Therapy-General\nNone found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- EQ-5D-5L, EuroQol Group EQ-5DTM\n- FACT-G, Functional Assessment of Cancer Therapy - General']
ans100 = ['None found.', 'None found.', 'None found.', '- EORTC QLQ-CIPN20, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20-item sensory subscale\n- PRO-CTCAE, Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events\n- NCS, Nerve Conduction Study\n- CSA, Cross Sectional Area', 'None found.', 'None found.', '- EORTC QLQ-CIPN20, Change in the sensory neuropathic pain score\n- EORTC QLQ-CIPN20, Motor and autonomic pain subscores\n- PRO-CTCAE, Numbness and Tingling\n- NCI-CTCAE 5.0, CIPN\n- Dose and number of cycles of planned chemotherapy and completed chemotherapy\n- Ultrasound (sural CSA and median CSA), Cross sectional area (CSA) of peripheral nerves\n- Nerve response derived from NCS (sural, tibial, and median), Amplitude, distal latency, and conduction velocity\n- Nerve fiber density in the skin (IENF/mm)\n- BMI\n- Age\n- Cancer staging\n- Types/dosages of systemic therapy\n- Race (white/non-white)\n- Use of analgesics or treatments for neuropathy\n- Cancer Type\n- Sex', 'None found.', "- QLQ-CIPN20, European Organisation for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire\n- Total Neuropathy Scale\n- NCI-CTCAE, US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events", 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.']
ans265 = ['None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- Skindex-16, Skindex-16\n- NCI PRO-CTCAE, NCI PRO-CTCAE\n- EuroQol EQ-5D 5L, EuroQol EQ-5D 5L', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.']
ans131 = ['None found.', '- MSQOL-54, Multiple Sclerosis Quality of Life-54 instrument', 'None found.', '- IPAQ-SF, The International Physical Activity Questionnaire - Short Form\n- DHQ, Diet Habits Questionnaire (modified)\nNone found for alcohol consumption and smoking.', '- Self-administered Comorbidity Questionnaire (SCQ)\n- MSPSS, Multidimensional Scale of Perceived Social Support\n- MSQOL-54, Multiple Sclerosis Quality of Life-54\n- FSS, Fatigue Severity Scale\n- HADS, Hospital Anxiety and Depression Scale\n- PDDS, Patient-Determined Disease Steps\n- UWSE, University of Washington Self-Efficacy', 'None found.', 'None found.', 'None found.', 'None found.', '- MSQOL-54, Multiple Sclerosis Quality of Life-54 questionnaire\n- FSS, Fatigue Severity Scale\n- HADS, Hospital Anxiety and Depression Scale\n- UWSE, University of Washington Self-Efficacy Scale\n- None found.', '- DHQ, Dietary Habits Questionnaire\n- HADS, Hospital Anxiety and Depression\n- UWSE-6, Self-efficacy\n- MSPSS, Perceived social support\n- MSQOL54.pdt\n- FSS, Fatigue Severity Score questionnaire\n- MSOC Qualitative interviews.docx\n- Participant Information form.docx\n- Withdrawal form - MSOC - RCT.docx\n- Effectiveness survey.pdf\n- MSOC protocol.pdf', 'None found.', 'None found.', 'None found.']
ans175 = ['None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- EQ-5D-5L, The EQ-5D is a standardized, generic measure of health status that provides information on HRQOL and activities of daily living: mobility, self-care, usual activities, pain/discomfort and anxiety/depression\n- EQ-VAS, The EQ-VAS records the respondent\'s self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled "the best health you can imagine\\\' (100) and "the worst health you can imagine\\\' (0)', 'None found.', 'None found.', 'None found.', 'None found.', '- EQ-5D-5L, Health Questionnaire\n- VAS, Visual Analog Scale \n- E0-5D-5L, Cuestionario de Salud', 'None found.', 'None found.'] 
ans298 = ['None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'CTCAE, Common Terminology Criteria for Adverse Events\nAvelumab, Permanently discontinue avelumab therapy, Increase frequency of monitoring to every 3 days, Continue and initiate supportive care per Section 9.0, Consider renal biopsy, Taper steroids over at least 1 month, and resume avelumab therapy following steroids taper., Add prophylactic antibiotics for opportunistic infections, Creatinine increased > 6 x ULN, Nephrology consult, Myocarditis, New onset of cardiac signs or symptoms and / or new laboratory cardiac biomarker elevations (e.g. troponin, CK-MB, BNP) or cardiac imaging abnormalities suggestive of myocarditis., Guideline based supportive treatment as appropriate as per cardiology consult.*, Immune-mediated myocarditis, Endocrine Disorders, Endocrinology consult if needed, Rule-out secondary endocrinopathies (i.e. hypopituitarism / insufficiency, type I diabetes mellitus), Follow-up Management: Continue hormone (replacement/suppression: and monitoring of endocrine function as appropriate., Hypothyroidism, Hyperthyroidism, Adrenal insufficiency, Type I diabetes mellitus, For Grade 3 or 4 consider hospitalization, Endocrinology consult, If secondary thyroid and/or adrenal insufficiency is confirmed and/or low serum cortisol with inappropriately low ACTH) :, Refer to endocrinologist for dynamic testing as indicated and measurement of other hormones (FSH, LH, GH/IGF-1, PRL, testosterone in men, estrogens in women), Hypopituitarism/Hypophysitis, Hormone replacement/suppressive therapy as appropriate, Perform pituitary MRI and visual field examination as indicated, Pneumonitis, Pulmonary and Infectious Disease consults., Delay avelumab therapy pending clinical investigation, If irAE is ruled out, manage as appropriate according to the diagnosis and consider re-starting avelumab therapy, If irAE is confirmed, treat as Grade 2 or 3 irAE., 8.3, Dose Modifications for Cisplatin, 5-FU, and/or Mitomycin ( Based on Interval Adverse Events (occurring within a cycle of treatment)', 'CTCAE, Common Terminology Criteria for Adverse Events<br>None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 \n- EORTC QLQ-BLM30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Bladder Cancer Module 30', '- EORTC QLQ-C30\n- EORTC QLQ-BLM30']
ans193 = ['None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- FACT-P, Quality of life questionnaires\n- IIEF, Quality of life questionnaires\n- Brief Pain Inventory, Quality of life questionnaires', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- FACT-P, Functional Assessment of Cancer Therapy-Prostate instrument\n- IIEF, International Index of Erectile Function']
ans333 = ['None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire\n- FKSI-15, FACT-Kidney Symptom Index - 15\n- PSS, Perceived Stress Scale \n- RECIST, Response Evaluation Criteria in Solid Tumors (version 1.1)', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- EORTO QLQ-C30, FKSI-15, PSS, questionnaires', 'None found.', '- EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire\n- FKSI-15, FACT-Kidney Symptom Index - 15', '- PSS, Perceived Stress Scale']
ans609 = ['DLQI, Dermatology Life Quality Index', 'None found.', 'None found.', "- DLQI, Dermatology Life Quality Index\n- PASI, Psoriasis Area and Severity Index\n- PPPASI, Palmoplantar Pustulosis Psoriasis Area and Severity Index\n- PGA, Physician's Global Assessment\n- Dynamic H&F PGA, Dynamic Hand and Feet Physician's Global Assessment\n- H&F PGA, Hand and Feet Physician's Global Assessment\n- VAS, Visual Analogue Scale", 'None found.', 'None found.', '- DLQI, Dermatology Life Quality Index\n- PPPASI, Palmoplantar Pustular Area and Severity Index\n- VAS, Visual Analog Scale', 'None found.', 'None found.', 'None found.', 'DLQI, Dermatology Life Quality Index', "- DLQI, Dermatology Life Quality Index \n- PASI, Psoriasis Area and Severity Index \n- PPPASI, Palmoplantar Pustulosis Psoriasis Area and Severity Index \n- PGA, Physician's Global Assessment \n- Dynamic H&F PGA, Dynamic Hand and Feet Physician's Global Assessment \n- H&F PGA, Hand and Feet Physician's Global Assessment \n- VAS, Visual Analogue Scale", 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- DLQI, Dermatology Life Quality Index', '- DLQI, Dermatology Life Quality Index\n- PASI, Psoriasis Area and Severity Index\n- PPPASI, Palmoplantar Pustulosis Psoriasis Area and Severity Index', "- Physician's Global Assessment (PGA)\n    - Plaque elevation = 0 (no elevation over normal skin)\n    - Scaling = 0 (no evidence of scaling)\n    - Erythema = 0 (except for residual hyperpigmentation/hypopigmentation)\n    - Plaque elevation = I (possible but difficult to ascertain whether there is a slight elevation above normal skin)\n    - Scaling = (surface dryness with some desquamation)\n    - Erythema = 1 (faint, diffuse pink or slight red coloration)\n    - Plaque elevation = slight (slight but definite elevation, typically edges are indistinct or sloped)\n    - Scaling = fine (fine scale partially or mostly covering lesions)\n    - Erythema = mild (light red coloration)\n    - Plaque elevation = marked (marked definite elevation with rough or sloped edges)\n    - Scaling = coarser (coarser scale covering most or all of the lesions)\n    - Erythema = moderate (definite red coloration)\n    - Plaque elevation = marked (marked elevation typically with hard or sharp edges)\n    - Scaling = coarser (coarse, non tenacious scale predominates covering most or all of the lesions)\n    - Erythema = severe (very bright red coloration)\n- Dynamic Hand and Feet (H&F) PGA\n    - Cleared (0), 100%, Remission of all clinical signs and symptoms as compared with baseline, except for residual manifestations such as mild erythema\n    - Excellent (1), 75%-99%, Improvement of all clinical signs and symptoms as compared with baseline, except for residual manifestations such as mild erythema\n    - Good (2), 50%-74%, Improvement of all clinical signs and symptoms as compared with baseline\n    - Fair (3), 25%-49%, Improvement of all clinical signs and symptoms as compared with baseline\n    - Slight (4), 1%-24%, Improvement of all clinical signs and symptoms as compared with baseline\n    - Unchanged (5), Clinical signs and symptoms unchanged from baseline\n    - Worse (6), Clinical signs and symptoms deteriorated from baseline\n- Hand and Feet (H&F) PGA\n    - Clear, No signs of plaque psoriasis on the hands and / or feet\n    - Almost Clear, Just perceptible erythema and just perceptible scaling on the hands and/ or feet\n    - Mild, Light pink erythema with minimal scaling and with or without pustules on the hands and / or feet\n    - Moderate, Dull red, clearly distinguishable erythema with diffuse scaling, some thickening of the skin, with or without fissures, and with or without pustule formation on the hands and / or feet\n    - Severe, Deep/ dark red erythema with clearly obvious and diffuse scaling and thickening, and numerous fissures with or without pustule formation on the hands and / or feet\n- Visual Analogue Scale (VAS)\n    - Patient's assessment of pruritus / itch\n    - On average, how much itch have you had because of your condition in the past week?\n    - Please use a vertical stroke\n    - No itch at all, Worst itch imaginable, 0 mm, 100 mm\n    - Patient's assessment of skin discomfort / pain\n    - On average, how much skin discomfort / pain have you had because of your condition in the past week?\n    - Please use a vertical stroke\n    - No pain at all, Worst possible pain, 0 mm, 100 mm"]
ans684 = ['None found.', 'None found.', '- CES-D, Center for Epidemiologic Studies-Depression scale\n- PSS, Perceived Stress Scale\n- Impact of Events Scale\n- Quality of Life in Adult Cancer Survivors questionnaire\n- Fatigue Symptom Inventory\n- Pittsburgh Sleep Quality Index\n- BCPT symptom scales\n- Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.']
ans49 = ['None found.', 'None found.', '- DTR-QOL Questionnaire\n- HbAlc\n- Diabetes Therapy-Related QOL (DTR-QOL) Questionnaire\n- Diabetes Treatment Satisfaction Questionnaire (DTSQ)', 'None found.', '- DTSQ, Diabetes Treatment Satisfaction Questionnaire\n- DTR-QOL, Diabetes Therapy-Related QOL\n- FDA, US Food and Drug Administration\n- QOL, Quality Of Life\n- SAE, serious adverse event\n- MedDRA, Medical Dictionary for Regulatory Activities\n- EQ-5D, European Quality of Life 5-Dimension Questionnaire (not found in text, but commonly used questionnaire in clinical trials)', 'None found.', 'DTR-QOL questionnaire', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- Diabetes Therapy-Related QOL (DTR-QOL) questionnaire\n- Diabetes Treatment Satisfaction Questionnaire (DTSQ)', 'None found.', 'None found.', 'None found.', '- DTSQ, Diabetes Treatment Satisfaction Questionnaire \n- DTR-QOL, Diabetes Therapy-Related QOL', '- DTR-QOL Questionnaire\n- Diabetes Treatment Satisfaction Questionnaire (DTSQ)', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'DTR-QOL questionnaire', 'None found.', 'None found.']
ans1546 = ['None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Scale\n- Medical Research Council (MRC) Breathlessness Scale\n- EQ-5D-3L Scale\n- Satisfaction Questionnaire', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.']
ans1604 = ["- CDAI, Crohn's Disease Activity Index\n- SES-CD, Simple Endoscopic Score for Crohn's Disease\n- IBDQ, Inflammatory Bowel Disease Questionnaire\n- SF-36, Short Form 36 Health Survey", 'None found.', 'None found.', 'None found.', 'None found.', '- Inflammatory Bowel Disease Questionnaire, IBDQ', 'None found.', 'None found.', 'None found.', 'None found.', "- CDAI, Crohn's Disease Activity Index\n- PRO, Patient Reported Outcome\n- BSFS, Bristol Stool Form Scale\n- SES-CD, Simple Endoscopic Score for Crohn's Disease\n- CD, Crohn's Disease", 'None found.', 'None found.', 'None found.', "- Patient-reported Outcome - Crohn's Disease Daily E-diary\n- Simple Endoscopic Score for Crohn's Disease", '- Inflammatory Bowel Disease Questionnaire, IBDQ\n- Short Form-36 Health Survey, SF-36', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', "- IBDQ, Inflammatory Bowel Disease Questionnaire\n- SF-36, Short Form-36 Health Survey\n- BSFS, Bristol Stool Form Scale\n- CDAI, Crohn's Disease Activity Index\n- SES-CD, Simple Endoscopic Score for CD", 'None found.', '- SF-36, Short Form-36 Health Survey (Version 2, Acute Form)\n- FSH, Follicle-stimulating Hormone Test\n- Serum B-hCG, Serum beta-human chorionic gonadotropin pregnancy test\n- TB test (QuantiFERON-TB Gold Plus or PPD), Tuberculosis Test (QuantiFERON-TB Gold Plus or Purified Protein Derivative)\n- Hematology\n- Serum chemistry\n- HBsAg Hepatitis B surface antigen\n- HBcAb Hepatitis B core antibody\n- HCV Ab, Hepatitis C antibody\n- HBV DNA, Hepatitis B virus DNA test\n- HIV, Human immunodeficiency virus test', 'None found.', 'None found.', 'Short Form-36 Health Survey (Version 2), Acute Form', "- CDAI, clinical disease activity index\n- IBDQ, Inflammatory Bowel Disease Questionnaire\n- SF-36, Short Form-36 Health Survey\n- SES-CD, Simple Endoscopic Score for Crohn's Disease", 'None found.', 'None found.', 'None found.', 'None found.']
ans1617 = ['SF-20 20 items from the SF-36 Health Survey', 'DFS-SF Diabetic Foot Ulcer Scale- Short Form', 'VAS Visual Analogue Scale for Pain', 'Katz ADL Katz Index Independence in Activities Daily Living', 'SF-20 Health Survey', 'DFS-SF', 'Visual Analogue Scale for Pain (VAS)', 'KATZ ADL', 'SilhouetteStar', 'SilhouetteConnect', 'Wagner Classification System', 'Cytal® Wound Matrix 1-Layer', 'Fibracol™ sheet']
ans1552 = ['None found.', 'None found.', 'None found.', '- Kansas City Cardiomyopathy Questionnaire (KCCQ)\n- EuroQol five-dimensional five-level questionnaire (EQ-5D-5L)\n- Patient global impression of severity (PGIS)\n- Patient global impression of change (PGIC)', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- KCCQ, Kansas City Cardiomyopathy Questionnaire']
ans1592 = ['None found.', 'None found.', '- Modified Composite Assessment of Index Lesion Severity (mCAILS)\n- Modified Severity-Weighted Assessment Tool (mSWAT)', 'None found.', '- mCAILS, Modified Composite Assessment of Index Lesion Severity\n- mSWAT, Modified Severity-Weighted Assessment Tool\n- Skindex29, Skindex 29 Quality of Life Assessment Scale score', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- Skindex 29 Dermatology Survey of Quality of Life\n- Patient global assessment of improvement\n- Pruritus NRS (Numeric Rating Scale)', '- Skindex 29 questionnaire\n- Pruritus assessment\n- mCAILS assessment\n- mSWAT assessment', 'FCBP, Females of childbearing potential\nPK, PK assessment\nSkindex 29, Skindex 29 questionnaire\nmCAILS, modified Cutaneous Assessment Tool Lymphoma Severity score\nmSWAT, modified Severity-Weighted Assessment Tool\nCTCL, Cutaneous T-Cell Lymphoma\npruritus assessment', '- Skindex 29 questionnaire\n- mCAILS assessment\n- mSWAT assessment', 'None found.', 'None found.', 'None found.', '- Modified Composite Assessment of Index Lesion Severity (mCAILS)\n- Modified Severity-Weighted Assessment Tool (mSWAT)', 'Skindex 29 Dermatology Survey of Quality of Life\n\nPatient Global Assessment of Improvement and Pruritus Numeric Rating Scale (NRS)', 'None found.']
ans16172 = ['None found.', 'None found.', '- SF-20, 20-item subset of SF-36 Health Survey\n- DFS-SF, Diabetic Foot Ulcer Scale- Short Form\n- VAS, Visual Analogue Scale for Pain\n- Katz ADL, Katz Index of Independence in Activities of Daily Living', 'None found.', 'None found.', '- SF-20 Health Survey\n- DFS-SF\n- Visual Analogue Scale for Pain (VAS)\n- KATZ ADL\nNone found.', 'None found.']
ans1705 = ['None found.', 'None found.', 'None found.', 'None found.', '- FACT-O, Patient Reported Outcomes\n- EQ-5D-5L', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- FACT-O, Functional Assessment of Cancer Therapy-Ovarian questionnaire\n- EQ-5D-5L, European Quality of Life 5-Dimension 5-Level Questionnaire', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.']
ans1706 = ['None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- EORTC QLQ C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - 30 item Core Module\n- FACT-G, Functional Assessment of Cancer Therapy - General\n- FDA, Food and Drug Administration\n- FDG-PET, Fluorodeoxyglucose Positron Emission Tomography\n- GSK, GlaxoSmithKline\n- HNSCC, Head and Neck Squamous Cell Carcinoma/Cancer\n- HPV, Human Papilloma Virus\n- HRQoL, Health-related Quality of Life\n- ICF, Informed Consent Form\n- ICH, International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use\n- IHC, Immunohistochemistry\n- IL, Interleukin\n- INR, International Normalized Ratio\n- IRB, Institutional Review Board\n- kg, Kilogram(s)\n- LVEF, Left Ventricular Ejection Fraction\n- mAb, Monoclonal Antibody\n- MedDRA, Medical Dictionary for Regulatory Activities\n- ug, Microgram(s)\n- mg, Milligram(s)\n- mmHg, Millimeters of Mercury\n- mL, Milliliter(s)\n- MRI, Magnetic Resonance Imaging\n- irAE, Immune-related Adverse Event', 'None found.', 'None found.', '- None found.', 'None found.', 'None found.', 'None found.']
ans1680 = ['None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.', '- Insomnia Severity Index\n- Hospital Anxiety and Depression Scale (HADS)', 'None found.', 'None found.', 'None found. The provided text is not a valid questionnaire in any known format.', 'None found.', 'None found.', 'None found.', 'None found.', 'None found.']